Back to Rounds

Pre-Seed Round

Funding Details

Nuclide Therapeutics is a biotechnology startup focused on developing innovative therapeutic solutions for various diseases, leveraging advanced technologies in drug discovery and development. The company aims to address unmet medical needs through its proprietary platform that integrates artificial intelligence and machine learning to enhance drug discovery processes.

Confidence Score
Data extraction confidence: 90%
Participating Investors

No investors recorded for this funding round.

Related Tweets

No tweets found for this funding round.